Today: 29 April 2026
Snap stock slips again ahead of earnings — here’s what traders are watching
4 February 2026
1 min read

Snap stock slips again ahead of earnings — here’s what traders are watching

New York, Feb 4, 2026, 10:48 (EST) — Regular session

Snap Inc (SNAP.N) shares dropped roughly 1% to $6.03 in mid-morning trading on Wednesday, deepening losses ahead of the Snapchat parent’s earnings report after the bell.

The stock dropped 8.4% Tuesday, ending the day at $6.10 — marking its fourth day in a row of losses. Trading volume surged to more than double the 50-day average, according to MarketWatch data. Snap’s shares now trade roughly 48% below their 52-week peak of $11.71.

The report comes amid a shaky phase for tech following Tuesday’s drop in major stocks. “We’re seeing a lot of software companies across the spectrum get hit,” noted Art Hogan, chief market strategist at B. Riley Wealth. John Campbell from Allspring added that expectations were “really high.” Reuters

Snap plans to release its Q4 and full-year 2025 results after U.S. markets close, with a webcast set for 2 p.m. PT (5 p.m. ET), per its investor website.

Revenue estimates hover near $1.70 billion, but earnings forecasts vary widely. Some predict an adjusted profit close to 15 cents per share, while others expect a loss around 3 cents. Adjusted earnings exclude items like stock-based compensation to better reflect the underlying business performance.

Investors are eyeing Snap’s big push into augmented reality. Last week, the company announced plans for a standalone unit focused on its “Specs” smart glasses. It’s opening the door to minority investors and hiring nearly 100 people ahead of the launch, aiming to compete with Meta’s Ray-Ban glasses and Google’s partnership with Warby Parker. CEO Evan Spiegel revealed that Snap has poured over $3 billion into AR glasses development over 11 years. Reuters

The downside scenario is straightforward: any more cautious forecasts or hints that ad spending is pulling back could weigh on a stock already trading near its lows. Policy risks have resurfaced in Europe, where Spain and Greece proposed bans targeting teen social media use. Snap criticized Australia’s comparable legislation, saying it “leaves significant gaps that could undermine its goals.” Reuters

All eyes now turn to the report after the bell, particularly management’s take on 2026—ad demand, user trends, and just how aggressively Snap bets on Specs.

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
GOOG stock price drops as Alphabet earnings loom and DOJ appeal adds fresh antitrust risk
Previous Story

GOOG stock price drops as Alphabet earnings loom and DOJ appeal adds fresh antitrust risk

Booking Holdings (BKNG) stock price slips as analysts spar over AI risk ahead of Feb. 18 results
Next Story

Booking Holdings (BKNG) stock price slips as analysts spar over AI risk ahead of Feb. 18 results

Go toTop